CSIMarket
 


Dentsply Sirona Inc   (XRAY)
Other Ticker:  
 

Cumulative Dentsply Sirona Inc 's Long Term Debt to Equity for Trailing Twelve Months Period

XRAY's Long Term Debt to Equity for Trailing Twelve Months Period and Long Term Debt, Equity growth


Select the Comparisons : Select the Ratio:

XRAY Long Term Debt to Equity for Trailing Twelve Months Period

(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Equity Growth -6.72 % -23.48 % -25.21 % -23.71 % -28.62 %
Y / Y Long Term Debt Growth 3.8 % 1.88 % -1.6 % -4.55 % -9.77 %
Long Term Debt to Equity for Trailing Twelve Months Period 0.5 0.49 0.45 0.42 0.4
Total Ranking # 1516 # 1556 # 1539 # 1658 # 1528
Seq. Equity Growth -8.94 % 1.76 % -4.56 % 5.48 % -25.3 %
Seq. Long Term Debt Growth -2.06 % -0.05 % 0.88 % 5.12 % -3.87 %


Long Term Debt to Equity for Trailing Twelve Months Period Comment for 12 Months ending at Sep 30 2023
On the trailing twelve months basis Despite long-term debt repayement of -2.06% in III. Quarter, Long Term Debt to Equity for Trailing Twelve Months Period improved to 0.5, above Dentsply Sirona Inc 's average Long Term Debt to Equity for Trailing Twelve Months Period.
Long Term Debt to Equity for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies in Medical Equipment & Supplies industry 76 other companies have achieved lower Long Term Debt to Equity for Trailing Twelve Months Period than Dentsply Sirona Inc . While total ranking remained unchanged compare to previous quarter at no. .

What is Long Term Debt to Equity Ratio?
What is XRAY selling?
Long Term Debt to Equity XRAY in the most recent quarter
Long Term Debt to Equity for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 77
Sector # 249
S&P 500 # 1553


Long Term Debt to Equity for Trailing Twelve Months Period Statistics
High Average Low
0.81 0.39 0.16
(June 30. 2012)   (March 31, 2010)




Companies with similar average Long Term Debt to Equity for Trailing Twelve Months Period for 12 months ending Sep 30 2023, within Medical Equipment & Supplies Industry Long Term Debt to Equity for Trailing Twelve Months Period
Novocure Limited  1.34 
Polypid Ltd   1.30 
Bioventus Inc   1.30 
Conmed Corporation  1.30 
3m Company  1.29 
Apollo Endosurgery inc   1.17 
Uphealth Inc   1.12 
Artivion Inc   1.12 
Dexcom Inc   0.96 
Haemonetics Corporation  0.92 
Viewray Inc   0.89 
Medinotec Inc   0.82 
Integra Lifesciences Holdings Corp  0.80 
Cadre Holdings Inc   0.78 
Icu Medical Inc  0.77 
Msa Safety Incorporated  0.77 
Carlisle Companies Incorporated  0.76 
Zimvie Inc   0.72 
Tandem Diabetes Care Inc   0.71 
Masimo Corp  0.71 
Stryker Corp  0.71 
Infusystem Holdings Inc  0.69 
Acutus Medical Inc   0.66 
Integer Holdings Corporation  0.66 
Cerus Corporation  0.65 
National Vision Holdings Inc   0.63 
Nevro Corp   0.61 
Neuronetics inc   0.61 
Strata Skin Sciences Inc   0.59 
Silk Road Medical Inc   0.57 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com